| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/20/2010 | US7700549 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | CA2495146C Oil composition |
| 04/20/2010 | CA2485600C 5-ht4 receptor antagonists for the treatment of heart failure |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/20/2010 | CA2358925C Compositions and methods for use in targeting vascular destruction |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/15/2010 | WO2010042886A2 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | WO2010042649A2 PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF |
| 04/15/2010 | WO2010042626A1 1-phenylpyrrole compounds |
| 04/15/2010 | WO2010042622A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives |
| 04/15/2010 | WO2010042512A2 Detection of atherosclerosis using indocyanine green |
| 04/15/2010 | WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010042419A1 Chewing gum containing low dose amounts of water soluble vitamins |
| 04/15/2010 | WO2010041983A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041726A1 Substituted tricyclic heteroaryl compound |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010041410A1 Agent for suppressing increases in cholesterol |
| 04/15/2010 | WO2010041290A1 Natural molecules extracted from bergamot tissues, extraction process and pharmaceutical use |
| 04/15/2010 | WO2010041017A2 Chewable gelled emulsions |
| 04/15/2010 | WO2010040803A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 04/15/2010 | WO2010012817A3 5ht7 receptor ligands and compositions comprising the same |
| 04/15/2010 | WO2009151907A3 Compositions and methods for using cells to treat heart tissue |
| 04/15/2010 | WO2009146218A3 Compounds including an anti-inflammatory pharmacore and methods of use |
| 04/15/2010 | WO2009125434A3 Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof |
| 04/15/2010 | WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 04/15/2010 | US20100095387 Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases |
| 04/15/2010 | US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 04/15/2010 | US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 04/15/2010 | US20100093863 Use of citrulline for preventing an increase in protein carbonylation and for treating diseases resulting therefrom |
| 04/15/2010 | US20100093861 Treatment of insulin resistance or diseases associated with insulin resistance |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |
| 04/15/2010 | US20100093826 Atropisomer of pyrrole derivative |
| 04/15/2010 | US20100093818 Benzimidazole derivatives |
| 04/15/2010 | US20100093812 Desferrithiocin polyether analogues |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093798 Cyclic modulators of chemokine receptor activity |
| 04/15/2010 | US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093788 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/15/2010 | US20100093785 Diamine derivatives |
| 04/15/2010 | US20100093777 Spiro-ring compound |
| 04/15/2010 | US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093758 Pyridine sulfonamide modulators of endothelin-a receptor |
| 04/15/2010 | US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives |
| 04/15/2010 | US20100093728 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 04/15/2010 | US20100093711 Organic compounds |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093687 Method Of Treating Disorder Related To High Cholesterol Concentration |
| 04/15/2010 | US20100093681 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 04/15/2010 | US20100093643 Cardioprotective compounds |
| 04/15/2010 | US20100093640 Ace-inhibitory peptides from whey and methods for providing the same |
| 04/15/2010 | US20100093636 Methods of treating inflammation |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093624 Peptide therapeutics that bind vegf and methods of use thereof |
| 04/15/2010 | US20100093620 Tyrosine-rich conopeptides |
| 04/15/2010 | US20100093615 Antibacterial compounds and processes for its production |
| 04/15/2010 | US20100093612 Integrin targeted cyclopeptide ligands, their preparation and use |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092532 Materials and Methods for Treating and Managing Angiogenesis-Mediated Diseases |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092479 Compositions and methods for treatment of viral diseases |
| 04/15/2010 | US20100092467 Prevention of tissue ischemia, related methods and compositions |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092450 Use of Hyaluronidase for the Prevention or Treatment of Arterial Hypertension or Cardiac Insufficiency |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092444 Platelet rich plasma formulations for cardiac treatments |
| 04/15/2010 | US20100092432 Cell preparation containing multipotential stem cells originating in fat tissue |
| 04/15/2010 | CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | CA2752429A1 Chewable gelled emulsions |
| 04/15/2010 | CA2740003A1 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | CA2738214A1 Chewing gum containing low dose amounts of water soluble vitamins |
| 04/15/2010 | CA2736930A1 1-phenylpyrrole compounds |
| 04/15/2010 | CA2736923A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174945A1 Antisense modulation of apolipoprotein B expression |
| 04/14/2010 | EP2174939A1 Pyranones useful as ATM inhibitors |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2174658A1 Compositions comprising nebivolol |
| 04/14/2010 | EP2173773A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 04/14/2010 | EP2173710A1 Novel crystalline form |
| 04/14/2010 | EP2173336A1 New use of known pharmacologically active chemical compounds |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1363636B1 A combination comprising levosimendan and a calcium source for the treatment of heart failure |
| 04/14/2010 | EP1347773B1 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |